You are required to be logged in to access the full website
Click here if you have forgotten your username or password
11 August 2026 - Swedish pharmaceutical company AcuCort AB (Spotlight Stock Market: ACUC), developer of the rapidly dissolving dexamethasone oral film Zeqmelit, on Tuesday announced that it has published results from its Phase IV study in the Journal...
11 August 2026 - Italian pharmaceutical company Alfasigma S.p.A. announced on Tuesday that it has entered into an agreement with SEVER Life Sciences B.V. to acquire 100% of Nordic Group B.V. and its subsidiaries, expanding its specialty pharmaceutica...
11 August 2026 - Dermatology company Galderma (SWX:GALD) said on Tuesday that it has received European Union approval under the Medical Device Regulation for Restylane Shaype, a hyaluronic acid injectable for temporary augmentation of the chin region...
11 August 2026 - Clinical-stage pharmaceutical company SoftOx Solutions AS (Euronext Growth Oslo:SOFTX) announced on Tuesday that the first patient has been dosed in the proof-of-concept phase of its SIS-03 clinical programme. The Phase 2a patient tr...
11 August 2026 - BSF Enterprise plc (LON:BSFA), a biotechnology company focused on tissue engineering, lab-grown materials and bioactive solutions, said on Tuesday that it has signed Heads of Terms with SCHAKAU Managementberatung GmbH for the worldwi...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe